Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03967132 · ClinicalTrials.gov registry record · NA
Growth and Tolerance of Infants Fed Milk-Based Infant Formula
A NA study of Gastro-Intestinal Tolerance, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 189
- Enrollment target
- 19
- Study locations
NCT03967132 is a NA study of Gastro-Intestinal Tolerance that has completed, run by Abbott Nutrition. The registered enrollment target is 189 participants. The trial reports 19 study locations across 10 states.
The verdict
NCT03967132, a NA study of Gastro-Intestinal Tolerance, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 189 participants
- Enrollment target
- 19
- Study locations
Study Summary
The purpose of this study is to evaluate growth and tolerance of healthy term infants fed an experimental milk-based infant formula with oligosaccharides compared to a control milk-based infant formula.
Conditions Studied
Interventions
- OTHER Experimental Infant Formula
- OTHER Control Infant Formula
- OTHER Reference Group
Study Locations (19)
Texas
- ARC Clinical Research at Wilson Parke - Austin
- Ventavia Research Group, LLC - Fort Worth
- Ventavia Research Group - Houston
- Ventavia Research Group, LLC 3078 - Keller
- Kagan Pediatrics - HD Research Corporation - Pearland
- Plano Pediatrics - ACRC Trials - Plano
Florida
- Phoenix Medical Research LLC - Miami
- University Clinical Research-Deland, LLC a/b/a Accel Clinical Research - Orlando
Kentucky
- Michael W. Simon, M.D., PSC - Nicholasville
- Springs Medical Research - Owensboro
Ohio
- Institute of Clinical Research, LLC - Mentor
- The Cleveland Pediatric Research Center, LLC - Middleburg Heights
Tennessee
- Holston Medical Group - Kingsport
- Midsouth Center for Clinical Research - Memphis
Arizona
- Watching Over Mothers & Babies - Tucson
California
- Pediatric Medical Associates - Sacramento
Connecticut
- Norwich Pediatric Group, P.C. - Norwich
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2019-06-08 |
| Est. Completion | 2020-05-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03967132
The ClinicalTrials.gov registry entry for NCT03967132 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastro-Intestinal Tolerance appearing as the primary indexed condition, and to 3 interventions - of which Experimental Infant Formula is the first listed.
NCT03967132 reports 19 study locations spanning 10 distinct geographic areas - top geographies include Texas, Florida, Kentucky.
Frequently Asked Questions
What is clinical trial NCT03967132 about?
NCT03967132 is a clinical study titled "Growth and Tolerance of Infants Fed Milk-Based Infant Formula". The purpose of this study is to evaluate growth and tolerance of healthy term infants fed an experimental milk-based infant formula with oligosaccharides compared to a control milk-based infant formula.
What is the current status of trial NCT03967132?
This trial is currently completed. It is a NA study. The enrollment target is 189 participants. The study started on 2019-06-08. Estimated completion is 2020-05-29.
What conditions does trial NCT03967132 study?
This clinical trial studies the following conditions: Gastro-Intestinal Tolerance.
What interventions are being tested in trial NCT03967132?
The interventions under investigation include: Experimental Infant Formula (OTHER), Control Infant Formula (OTHER), Reference Group (OTHER).
Who is sponsoring clinical trial NCT03967132?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03967132 being conducted?
This trial has 19 study locations across Arizona, California, Connecticut, Florida, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.